Evaluation of Endothelial Hyperglycemia-Driven Alterations During Type 2 Diabetes

2 型糖尿病期间内皮高血糖驱动变化的评估

基本信息

  • 批准号:
    9032837
  • 负责人:
  • 金额:
    $ 10.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-17 至 2019-07-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Diabetes currently afflicts approximately 25.8 million people in the United States (US) and 220 million people worldwide. Type 2 diabetes mellitus (T2DM) accounts for ~95% of all diagnosed cases in the US, among which cardiovascular disease is the leading cause of mortality. Vascular dysfunction, leading to increased risk of coronary artery disease and peripheral vascular disease, remains an important clinical problem in diabetic patients. Hyperglycemia is a major causative factor of T2DM contributing to vascular dysfunction, however, there is a large gap of mechanistic studies in this area. This proposal evaluates the underlying hyperglycemia- induced alterations in the endothelium glycoproteome that lead to changes in important homeostatic signaling pathways, such as the AT1R and HTR2A signaling pathways, and result in vascular dysfunction. The aims of this proposal utilize innovative glycoproteome and phosphoproteome enrichment, sensitive mass spectrometry technology, and physiologically relevant functional tests to explore hyperglycemia-induced protein glycosylation at the cell surface (Aim 1), alterations of the synergistic balance of intracellular O-GlcNAcylation and phosphorylation (Aim 2), and subsequent alterations in important homeostatic signaling pathways leading to vascular dysfunction (Aim 3). In order to do this, the applicant requires protected time for supervised career development in bioinformatics, proteomics as applied to physiological systems, vascular biology, clinically relevant human cohort experimentation, and professional development under the direction of Dr. Andrew Greene (Professor of Physiology-MCW) and co-mentor Dr. Michael Widlansky (Associate Professor of Medicine and Pharmacology-MCW). This research proposal and career development modules will assist in fostering the Principal Investigator in his independence such that he can lead a research program aimed at examining causal factors in T2DM. The mentored career development award will further the candidate's training in bioinformatics processing for signal pathway ontology analyses, along with continued training in proteomics analysis applied to complex systems. The applicant will also receive extensive training in vascular biology as it relates to functional studies of T2DM rat models and vessels from T2DM patients. The training agenda includes lab-based training (MCW), clinical training (MCW/Froedtert & CTSI), specialty training in external labs, coursework, and professional development seminars/workshops. This multi-disciplinary training will ensure the ability of the applicant to design, perform, troubleshot, and interpret experiments independently. Outcomes of research proposal described here will provide direct evidence to confirm or refute the fundamental hypothesis that hyperglycemia-induced glycosylation is driving specific alterations leading to vascular dysfunction in T2DM and in combination with the professional career development will foster a smooth transition of the candidate to an independently funded investigator.
 描述(由适用提供):目前,糖尿病在美国(美国)(美国)约2580万人和全球2.2亿人患者。 2型糖尿病(T2DM)占美国所有被诊断病例的95%,其中心血管疾病是死亡率的主要原因。血管功能障碍导致冠状动脉疾病和周围血管疾病的风险增加,仍然是糖尿病患者的重要临床问题。高血糖是导致血管功能障碍的T2DM的主要结构因子,但是,该地区的机械研究差距很大。该提案评估了内皮糖蛋白酶的潜在高血糖诱导的改变,从而导致重要的稳态信号传导途径发生变化,例如AT1R和HTR2A信号通路,并导致血管功能障碍。 The aims of this Proposal utilize innovative glycoproteome and phosphoproteome enrichment, sensitive mass spectrometry technology, and physically relevant functional tests to explore hyperglycemia-induced protein glycosylation at the cell surface (Aim 1), alterations of the synergistic balance of intracellular O-GlcNAcylation and phosphorylation (Aim 2), and subsequent alterations in important稳态信号通路导致血管功能障碍(AIM 3)。这是适用的时间来监督生物信息学,蛋白质组学的职业发展,适用于物理系统,血管生物学,临床相关的人类队列实验和专业发展,并在安德鲁·格林博士(Andrew Greene)(生理学MCW教授)和同事Michael Widlansky(Michael Widlansky(Medicic of Medicic and Pharmagic Accologe and Pharmagic Accologe and Pharmagic Accology and Pharmagical Coldicor and Pharmagiate and Pressigational of Medicialology-MCW)的指导下)进行了专业发展。这项研究建议和职业发展模块将有助于培养主要研究者的独立性,以便他可以领导旨在检查T2DM中灾难性因素的研究计划。 Mendored职业发展奖将进一步为候选人在信号途径本体分析的生物信息学处理方面的培训,以及对复杂系统的蛋白质组学分析的持续培训。适用的还将接受有关血管生物学的广泛培训,因为它与T2DM大鼠模型的功能研究和T2DM患者的视频有关。培训议程包括基于实验室的培训(MCW),临床培训(MCW/Froedtert&CTSI),外部实验室的专业培训,课程工作和专业发展半手/讲习班。这种多学科培训将确保申请人独立设计,执行,故障排除和解释实验的能力。此处描述的研究提案的结果将提供直接证据,以确认或驳斥高血糖诱导的糖基化的基本假设,即导致特定的改变,导致T2DM中的血管功能障碍,并结合职业职业发展将促进对独立资助的独立研究员的平稳转移。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brian Robert Hoffmann其他文献

Brian Robert Hoffmann的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brian Robert Hoffmann', 18)}}的其他基金

Evaluation of Endothelial Hyperglycemia-Driven Alterations During Type 2 Diabetes
2 型糖尿病期间内皮高血糖驱动变化的评估
  • 批准号:
    9322612
  • 财政年份:
    2015
  • 资助金额:
    $ 10.28万
  • 项目类别:
Evaluation of Endothelial Hyperglycemia-Driven Alterations During Type 2 Diabetes
2 型糖尿病期间内皮高血糖驱动变化的评估
  • 批准号:
    9145729
  • 财政年份:
    2015
  • 资助金额:
    $ 10.28万
  • 项目类别:

相似国自然基金

乙酰胆碱通过a7nAChR调控巨噬细胞极化对肩袖损伤愈合的影响及相关机制研究
  • 批准号:
    82102580
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
neuregulin1通过agrin/Lrp4/MuSK信号通路影响面肌和骨骼肌对肌松药敏感性差异的机制研究
  • 批准号:
    81870714
  • 批准年份:
    2018
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
基底前脑对听觉稳态反应的影响及其在精神分裂症听觉功能异常中的作用
  • 批准号:
    31671080
  • 批准年份:
    2016
  • 资助金额:
    62.0 万元
  • 项目类别:
    面上项目
迷走神经影响肺部微环境调控流感病毒感染、炎症和免疫反应
  • 批准号:
    91542105
  • 批准年份:
    2015
  • 资助金额:
    70.0 万元
  • 项目类别:
    重大研究计划

相似海外基金

Project 1: Modeling brain-state-dependent fluid flow and clearance in mice and humans
项目 1:模拟小鼠和人类大脑状态依赖性液体流动和清除
  • 批准号:
    10673158
  • 财政年份:
    2022
  • 资助金额:
    $ 10.28万
  • 项目类别:
Project 1: Modeling brain-state-dependent fluid flow and clearance in mice and humans
项目 1:模拟小鼠和人类大脑状态依赖性液体流动和清除
  • 批准号:
    10516501
  • 财政年份:
    2022
  • 资助金额:
    $ 10.28万
  • 项目类别:
Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics
卵巢激素对中枢和脑血管血流动力学的调节
  • 批准号:
    10548812
  • 财政年份:
    2021
  • 资助金额:
    $ 10.28万
  • 项目类别:
Covalent Inhibition as a Method to Counteract Botulinum Intoxication
共价抑制作为对抗肉毒杆菌中毒的方法
  • 批准号:
    10177867
  • 财政年份:
    2020
  • 资助金额:
    $ 10.28万
  • 项目类别:
Covalent Inhibition as a Method to Counteract Botulinum Intoxication
共价抑制作为对抗肉毒杆菌中毒的方法
  • 批准号:
    10408004
  • 财政年份:
    2020
  • 资助金额:
    $ 10.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了